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Tumor suppressor activity of miR-
451: Identification of CARF as a new 
target
Ling Li1,2, Ran Gao1,3, Yue Yu1,2, Zeenia Kaul4, Jia Wang1,2, Rajkumar S. Kalra1, Zhenya Zhang2, 
Sunil C. Kaul1 & Renu Wadhwa1
microRNAs (miRs) have recently emerged as small non-coding regulators of gene expression. We 
performed a loss-of-function screening by recruiting retrovirus mediated arbitrary manipulation of 
genome coupled with escape of cells from 5-Aza-2′-deoxycytidine (5-Aza-dC)-induced senescence. 
miRNA pool from cells that emerged from 5-Aza-dC-induced senescence was subjected to miR-
microarray analysis with respect to the untreated control. We identified miR-451 as one of the 
upregulated miRs and characterized its functional relevance to drug resistance, cell growth, tumor 
suppressor proteins p53 and pRb, and stress response. We report that miR-451 caused growth arrest 
in cells leading to their resistance to 5-Aza-dC-induced senescence. Decrease in cyclin D1, CDK4 and 
phosphorylated pRB supported the growth arrest in miR-451 transfected cells. We demonstrate that 
Collaborator of ARF (CARF) protein is a new target of miR-451 that intermediates its function in tumor 
suppressor and stress signaling.
Cancer also known as malignant neoplasm is a group of diseases involving abnormal cell growth and is extremely 
complex to understand and treat. According to World Health Organization (WHO), cancer caused 8.8 million 
deaths in 2015 and 30–50% of those could be prevented either by early diagnosis or improvement in therapeutic 
strategies. Current therapeutic solutions comprise surgical removal of detectable tumors and chemotherapy that 
is complicated by high toxicity, undesired secondary effects on normal body functions and drug resistance. Novel 
diagnostic markers and therapeutic drugs to improve the treatment are hence required.
MicroRNAs (miRNAs), single-stranded RNA of 18–24 nucleotides, first discovered in the early 1990s, have 
been recognized as noncoding regulators of gene functions including control of cell proliferation, differentiation, 
inflammation, stress response, apoptosis, carcinogenesis and metastasis1–3. Several miRNAs have been shown not 
only to act as tumor suppressors or oncogenes, but also serve as diagnostic markers important for the pathobiol-
ogy of tumors2,4. Many miRNAs get downregulated in tumors and hence have been called tumor suppressors2,4,5. 
On the other hand, several miRNAs have been found to be upregulated in tumors and ascribed to upregulate 
oncogenic functions2,5–7.
Downregulation of miR-451 has been reported in a variety of tumors including glioma8–11, breast carcinoma12, 
gastrointestinal carcinoma13, non-small cell lung carcinoma (NSCLC)14–17, hepatoma18–21, nasopharyngeal22, eso-
phageal23,24, bladder25, osteosarcoma26,27, epithelial ovarian28, renal29 and thyroid30 carcinomas. In several studies, 
it was shown to correlate with clinical stages of tumor including metastasis and poor response to neoadjuvant 
chemotherapy and recurrence26,27. Ling et al.28 examined the expression of miR-451 in 115 cancer and 34 normal 
ovarian tissues, and found correlation with clinicopathological factors and prognosis. Low level of miR-451 in 
ovarian cancer as compared with normal tissue was associated with advanced FIGO stage, higher serum CA125 
expression level and lymph node metastasis. Furthermore, transfection of miR-451 mimics in ovarian cancer cells 
reduced their cell proliferation, promoted cell apoptosis, and inhibited cell invasion suggesting that miR-451 is a 
potential candidate for therapy28. Study showed that reduced miR-451 was significantly correlated with advanced 
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clinical stage, metastasis and worse disease-free or overall survival in HCC tissues. Reconstitution of miR-451 
caused growth arrest of HCC, increased their chemo- or radio-sensitivity and reversed epithelial to mesenchymal 
transition (EMT)20,25. Furthermore, decrease in Bcl-2, AKT and p-AKT expression resulted in increased apopto-
sis in miR-451 overexpressing esophageal carcinoma23.
miR-451 has been shown to target PSMB8 in renal cell carcinoma and lung cancer16,29; MIF, LKB1/AMPK, 
AMPK/mTOR and Fascin1 in thyroid, glioma, nasopharyngeal and gastric carcinomas9,10,13,22,30; IKK-β in HCC19; 
CXCL16 in osteosarcoma26; CDKN2D and MAP3K1 in esophageal carcinoma24; liver receptor homolog-1 (LRH-1) 
that plays crucial role in the onset and progression of many cancer types31; c-Myc/Erk1–2 and ATF2 in hepato-
carcinoma20,21 and PI3K/Akt/mTOR in multiple myeloma32. Reconstitution of miRNA-451 inhibited cell cycle 
progression, cellular migration and the invasive ability of NSCLC cells. It was shown to target Ras-related protein 
14 (RAB14)15 and serve as a novel therapeutic drug to treat NSCLC patients. Ectopic overexpression of miR-451 
was shown to inhibit growth and induced apoptosis in A549 cells. It also sensitized them to cisplatin by inactiva-
tion of Akt signaling pathway17. miR-451 was shown to regulate the expression of multidrug resistance-1 gene. 
Transfection of the MCF-7/DOX-resistant cells with miR-451 sensitized them to DOX suggesting its implication 
for treatment of drug resistant cancer cells12.
In the present study, we used a bicistronic vector containing GFP reporter to arbitrarily induce miRs in human 
osteosarcoma33. Cells expressing such random library of miRs were subjected to 5-Aza-dC-induced senescence 
for 3–5 days. miR pool of cells that escaped senescence was subjected to miR-array analysis with respect to the 
control (untransfected) cells. Out of several upregulated miRs, we characterized the function of miR-451 in the 
present study. We report miR-451 caused growth arrest of cells that showed increase in p21WAF1, and decrease 
in CyclinD1, CDK4, phospho-pRB and E2F5 proteins. Expression and reporter assays demonstrated that these 
effects are mediated by targeting CARF.
Results
miR-451 possesses a tumor suppressor activity. Downregulation of miR-451 has been reported in 
several kinds of cancers in many recent studies16,20,27,34. By miR-array we detected miR-451 as an upregulated 
miR in cells that emerged from 5-AZA-dC-induced senescence in treated cultured cells as compared to the con-
trol. In light of this data, we performed real-time PCR assay in a variety of cancer and normal cells. Consistent 
with other reports, we found that all cancer cells possessed low level (~2–6 fold) of expression of miR-451 as 
compared to the normal cells (Fig. 1). Of note, in vitro immortalized lung fibroblasts (MRC5/hTERT) and lung 
tumor-derived cells (A549) showed lower level of expression as compared to the normal lung fibroblasts (MRC5) 
(Fig. 1). Furthermore, amongst several cancer cells, U2OS showed the lowest level of miR-451 expression (Fig. 1). 
We next overexpressed miR-451 in U2OS cells, and examined their proliferation rate with respect to the control 
(untransfected) and GFP-vector transfected cells. As shown in Fig. 2A, compared to the untransfected control 
and GFP-transfected cells, miR-451 overexpressing derivatives showed decrease in viability (Fig. 2A) and cell 
growth (Fig. 2B). Similar effect was observed in long-term survival and colony forming capacity (Fig. 2C and 
Supplementary Figure 1A). Cell cycle analysis of control and miR-derivatives revealed G0/G1 arrest of in the 
latter (Fig. 2D). In order to confirm that the effect was specific to miR-451, we recruited two other miRs (miR-
101 and −558) using identical vector and cell line. Whereas miR-101 and miR-558 promoted cell proliferation, 
as determined by short term (cell viability) and long term (cell growth and colony formation) assays, miR-451 
caused inhibition (Supplementary Figure 1B–D). However, contrary to our expectation, growth arrest in miR-451 
transfected cells were observed also in the presence of 5-AZA-dC (Supplementary Figure 1E). The data suggest 
that miR-451-induced growth arrest may prevent incorporation of 5-AZA-dC in cell genome and contribute to 
fast recovery of cells during subsequent culture in 5-AZA-dC free medium. In order to firmly confirm the growth 
inhibitory activity of miR-451, we performed in vivo tumor progression assays using subcutaneous xenograft 
model. As shown in Fig. 2E and F, significant growth retardation of miR-451-overexpressing A549 derivatives as 
compared to the control (untransfected cells) demonstrated that it is a tumor suppressor miR.
Figure 1. miR-451 is downregulated in cancer cells. Real-time PCR analysis of miR-451 in human normal 
and cancer cells showed its higher level of expression in normal cells. Cancer cells showed 2 to 10 fold less 
expression.
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Tumor suppressor activity of miR-451 is mediated by upregulation of p21WAF1, but not p53. In 
order to investigate the mRNA targets and clarify the mechanism of miR-451-mediated growth suppression, we 
performed expression analyses of major tumor suppressor proteins. As shown in Fig. 3A(a–e), miR-451 overex-
pressing cells (as identified by GFP fluorescence), showed decrease in pRB, its phosphorylated form and E2F-5 
(Fig. 3A,a,b) signifying cell cycle arrest. Consistent with these, upstream regulators of pRB-phosphorylation, 
CDK4 and Cyclin D1, showed decrease (Fig. 3A,c,d), in line with an increase in expression level of p21WAF1 
(an established mediator of growth arrest and inhibitor of cyclin/CDK complexes35) (Fig. 3A–e). These data 
were supported by immunofluorescence assay with specific antibodies (Fig. 3B,a–c). We performed real time 
RT-PCR for these candidate target genes, and found that in agreement with the protein expression data, mRNA 
for pRB, Cyclin D1 and CDK-4 was decreased in miR-451 derivatives (Fig. 3C). p21WAF1 on the other hand, 
showed increase that was also supported by p21WAF1 promoter-luciferase assays (Fig. 3D). Contrary to increase 
in p21WAF1, p53 specific promoter-luciferase assays did not real revealed significant change in the miR-451 deriv-
atives suggesting that p21WAF1 increase might be p53-independent (Fig. 3D). We examined the expression of 
p53 (its major transcriptional activator) and indeed found its decrease, both at the protein (Fig. 4A,B) as well as 
mRNA levels (Fig. 4C), in miR-451 derivatives. In line with this, HDM2 (antagonist for p53) protein and mRNA 
showed increase (Fig. 4D–F) that may account for decrease in p53.
miR-451 targets CARF and results in an upregulation of p21WAF1. We next explored the mechanism 
of miR-451 induced growth arrest that was marked by increase in p21WAF1 and hypo-phosphorylation of pRB. 
We have earlier reported that CARF (Collaborator of ARF) acts as a transcriptional repressor of HDM2 and 
p21WAF1. Based on the above results on upregulation of both p21WAF1 and HDM2 in miR-451 derivatives, we 
predicted that CARF could be one of the targets of miR-451. Analyses of protein as well as mRNA expression of 
CARF in control, vector and miR-451 derivatives revealed its remarkable decrease in the latter (Fig. 5A–C and 
Figure 2. miR-451 overexpression inhibited cancer cell proliferation in vitro and in vivo. Viability of 
control (untransfected), GFP and miR-451 overexpressing cells showed less number of viable cells in the latter 
(A). Growth curve analysis revealed that miR-451 overexpression suppressed U2OS cell growth as compared 
to the control (untransfected) and GFP-expressing cells (B). Long term survival by colony forming assay 
showed reduction (60% and 40% in U2OS and Saos-2, respectively) of cell colonies in miR-451 overexpressing 
derivatives (C). Cell cycle analysis revealed increase in number of cells at G0/G1 phase and decrease in 
number of cells at G2/M and S phases (D). Tumor growth assays in subcutaneous xenograft of control 
(untransfected) and miR-451 overexpressing cells showed reduced tumor forming capacity of the miR-451 
derivatives as compared to the control cells (E). Body weight of the mice during the course of experiment 
showed no difference (E).
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Supplementary Figure 1F). Furthermore, increase in p21WAF1, HDM2 and decrease in CARF was observed in p53 
deficient Saos-2-miR 451 derivative cells (Fig. 5D) suggesting that increase in p21WAF1 was independent to that of 
p53, and CARF is a candidate new target for miR-451. For conclusive validation, we performed reporter assays 
using CARF, p53 and p21 3′UTR-luciferase constructs. As shown in Fig. 5E, miR-451 caused reduction in CARF, 
and not p53 or p21WAF1 mRNA. These data confirmed that miR-451 targets CARF, and not p53 or p21WAF1.
CARF targeting by miR-451 and miR-335 induce apoptosis. CARF has been shown to pose two-way 
control on cell proliferation36–40. Its knockdown was lethal for cells in vitro and in vivo suggesting that it is an 
essential protein for cell survival40. A variety of cellular senescence models endorsed that the overexpression 
of CARF caused growth arrest of cancer cells and plays a definitive role in replicative as well as stress-induced 
Figure 3. miR-451 overexpression mediated growth arrest involves upregulation of pRB and p21WAF1 tumor 
suppressor pathways. miR-451 overexpressing derivatives that showed growth arrest possessed lower level of 
expression of pRB, phospho-pRB, E2F-5, CDK4 and cyclin D1, and higher level of expression of p21WAF1 as 
compared to the control (untransfected) cells and determined by Western blotting (A) and immunostaining 
(B). mRNA expression analyses revealed, decrease in the level of pRb, cyclin D1, CDK4 and increase in 
p21WAF1 in miR-451 overexpressing cells (C). p53 dependent promoter driven-reporter assays in control 
(untransfected) and miR-335 transfected cells showed upregulation of p21WAF1 and no change in p53 (D).
www.nature.com/scientificreports/
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Figure 4. miR-451 overexpressing cells showed downregulation of p53 and upregulation of HDM2. miR-451 
overexpressing derivatives possessed lower level of expression of p53 protein as well as mRNA levels (A–C). 
HDM2 was upregulated in miR-451 overexpressing as compared to the control (untransfected) cells at both 
mRNA and protein levels (D–F).
Figure 5. miR-451 directly targets CARF, but not p53. Western blotting (A) immunostaining (B) and qRT-
PCR (C) analysis for CARF showed decreased level of expression in miR-451 overexpressing as compared 
to the control (untransfected) cells. Increase in p21WAF1 and HDM2 occurred in p53−/− (Saos-2) cells (D). 
3′UTR reporter assay for CARF, p21WAF1, p53 in control and miR-451 overexpressing cells showed that miR-451 
directly targets CARF (E).
www.nature.com/scientificreports/
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senescence36,39–41. Super-high level of CARF expression has been associated with malignant transformation of 
cancer cells. Molecular mechanism(s) on the role of CARF in such dual regulation of cell proliferation has not 
been resolved as yet. In loss-of-function screening to identify miRNAs involved in 5-Aza-dC-induced senes-
cence, we earlier identified miR-335 that was confirmed to target CARF33. It was shown that miR-335 caused 
growth arrest in cancer cells and hence inhibited incorporation of 5-Aza-dC in genome33. In view of this, we 
co-transfected the cells with miR-451 and miR-335 and examined the cell phenotype. As shown in Fig. 6A, cells 
co-transfected with miR-335 and miR-451 showed stronger knockdown of CARF resulting in apoptosis as con-
firmed by apoptotic markers including cleavage of procaspase-3 and decrease in anti-apoptotic protein, Bcl-2 
(Fig. 6A). FACS analysis of control (untransfected) and double (miR-335 and 451)-transfected cells also con-
firmed higher rate of apoptosis in the latter (Fig. 6B).
In order to further prove the regulation of CARF by miR-451, we recruited seven chemical stress models that 
represented a variety of environmental stresses (Fig. 7A–C). Normal human fibroblasts (TIG-3) were treated with 
stress inducing agents that caused apoptosis, endorsed by decrease in CARF (Fig. 7A and B). Of note, consistent 
with the decrease in CARF, miR-451 showed increase (Fig. 7C). Furthermore, we found that the cells treated with 
herbal extract were protected from apoptosis. They showed recovery in CARF expression. Of note, increase in 
CARF was accompanied by decrease in miR-451 in stress-recovered cells (Fig. 7A–C). These data supported that 
miR-451 regulates CARF as well as stress response of cells.
Discussion
Collaborator of ARF (CARF) was first reported as a binding partner and collaborator of ARF (p14Alternate Reading Frame 
protein) by yeast two-hybrid screening42. It has been shown to regulate proliferative fate of cells; cellular senes-
cence, apoptosis and malignant transformation by dose dependent two-way regulatory pathways36–40. It has been 
established that CARF is essential for cell survival; its knockdown causes apoptosis. Furthermore, whereas over-
expression of CARF was shown to be associated with senescence related growth arrest of cells, its super high level 
of expression was correlated with malignant transformation of cancer cells38. Consistent with these findings, 
CARF has been shown to be upregulated in a variety of cancer cells40,43 and involved in cancer metastasis20. 
Recently we reported that the tumor suppresser miR-335 directly targets CARF and regulates cell cycle33.
In the present study, we recruited retroviral vector constituting two long terminal repeat (LTR) promoters on 
the 5′ and 3′ ends of the gene. Upon random integration of the vector in the genome, it resulted into expression of 
Figure 6. miR-335 and miR-451 co-transfection caused stronger knockdown of CARF resulting in apoptosis of 
cells. miR-4335 and miR-451 double derivatives showed stronger knockdown of CARF resulting in decrease in 
pro-caspase-3, pro-PARP-1 and Bcl-2 (A) and apoptosis (B).
www.nature.com/scientificreports/
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GFP; detected by green fluorescence. At the same time, it caused integration-dependent arbitrary manipulation 
of the host cell genome leading to altered expression of either proteins or miRs, and thereby loss-of-function 
phenotype, escape from induction of senescence in cancer (U2OS) cells by 5-Aza-dC (demethylating drug). The 
cells that evaded senescence were selected and subjected to microRNA array33. We found that several miRNAs 
(miR-101, miR-143, miR-335, miR-145, miR-451, miR-545 and miR-558) were upregulated in vector-transduced 
cells that showed resistance to 5-Aza-dC-induced senescence33. We earlier demonstrated that miR-335 was regu-
lated by methylation and silenced in a variety of tumors. Similar to miR-335, miR-451 caused growth suppression 
in vitro and in vivo. Furthermore, targeting of CARF by both miR-451 and miR-335 was confirmed by double 
transfections of cells that caused stronger knockdown of CARF (Fig. 6). We found that miR-451-induced growth 
arrest was mediated by increase in p21WAF1 and consequent decrease in Cyclin D1, CDK4, pRBPhospho and E2F5. 
These changes were independent of p53 status of the cells and mediated by targeting CARF, as endorsed by 
protein, mRNA and 3′UTR reporter assays. Increase in CARF has earlier been reported in response to stress 
and replicative senescence36,37,39,40. We found that miR-451 plays role in such regulation of CARF. It showed 
increase in response to a variety of stresses that caused decrease in CARF (Fig. 7). Of note, when cells were 
protected against stress by treatment with a herbal extract, both miR-451 and CARF showed some recovery to 
the normal unstressed levels suggesting a tight correlation of miR-451 with CARF. In order to further examine 
miR-451-driven regulation of CARF, we performed sequence based analyses using TargetSpy, a knowledge based 
online portal comprising broad-range compositional, physical, and combinatorial base-pairing algorithms that 
predicted miR-451 target sequence in CARF/CDKN2AIP 3′UTR transcript (NM_017632) located at 448–465 
base position (Supplementary Figure 1G). Taken together, we demonstrate that CARF is a new target of miR-451 
that mediates its tumor suppressor function in normal and stressed biological states.
Materials and Methods
Cell culture. All human cancer and normal cells were purchased from Japanese Collection of Research 
Bioresources (JCRB), Japan. Human osteosarcoma (U2OS, MG-63 and Saos-2), colorectal adenocarcinoma 
(DLD-1 and SW620) breast adenocarcinoma (MCF7), lung carcinoma (A549), immortalized lung fibroblasts 
(MRC5/hTERT) and normal human fibroblast (TIG-3 and MRC5) were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM; Gibco BRL, Grand Island, NY, USA) supplemented with 10% (v/v) fetal bovine serum (Gibco 
BRL), and 1% (v/v) penicillin/streptomycin in the presence of 5% CO2 at 37 °C.
Figure 7. miR-451 regulates stress response of cells through CARF signaling. Phenotype of human fibroblasts 
under normal and a variety of stressed conditions (as shown in the table) (A). Western blotting showing 
decrease in CARF associated with apoptosis of stressed cells and its recovery in cells treated with a herbal 
extract (B). miR-451 expression was upregulated in stressed as compared to the untreated control cells, and 
showed downregulation in recovered cells (C).
www.nature.com/scientificreports/
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RNA extraction, reverse transcription and real-time reverse transcription- polymerase chain 
reaction. Total RNA was isolated and quantitated from cells using the Relia Prep RNA Cell Miniprep System 
(Promega, Madison, WI, USA) and NanoDrop ND-1000 (Nanodrop Technologies, Wilmington, DE, USA), 
respectively. Pure RNA with A260/A280 ratio >1.9 was used for reverse transcription using QuantiTect Reverse 
Transcription Kit (Qiagen, Hilden, Germany) following the manufacturer’s instructions. The cDNA thus obtained 
was used for real-time qRT-PCR (50 °C for 2 min; 95 °C for 10 min, 40 cycles of 95 °C for 15 s, 60 °C for 1 min; and 
72 °C for 30 s) using SYBR®Select Master Mix (Applied Biosystems, CA, USA) in triplicate on the EcoTM real 
time system (lllumina, San Diego, CA, USA). The results of real-time qRT-PCR were normalized to the geometric 
mean of the 18 s internal control gene for variability in expression levels, then calculated as 2−[(Ct, Target gene − Ct, 18s) 
Time x −(Ct, Target gene − Ct, 18s) Time 0] following the manufacturer’s instructions, where Ct represents the threshold cycle 
for each transcript. The sequence of primers used is listed in Table 1.
In order to detect the expression level of miR-451 in cells, the corresponding miR-451 (Assay ID: 464419 
mat) and RNU6B (Assay ID: 001093) primers and TaqMan® MicroRNA assay were performed following manu-
facturer’s instructions (Applied Biosystems, CA, USA). Real-time qRT-PCR was performed at 95 °C for 10 min, 
40 cycles of 95 °C for 15 s and 65 °C for 1 min. The miR-451 expression data were normalized to the endogenous 
control based on the threshold cycle (Ct) calculated as 2−[(Ct, miR-451 − Ct, RNU6B) Time x −(Ct, miR-451 − Ct, RNU6B) Time 0]. Stem 
loop sequence of miR-451 and RNU6B are showed in Table 2.
Cloning of miR-451, expression plasmid and transfection. pCXGb-miR-451 encoding GFP and 
miR-451 driven by chicken β-actin promoter was generated by amplification of miR-451 from human genomic 
DNA by PCR using following primers: Sense 5′AAAGTCGACAAGCTCTCTGCTCAGCCTGTC3′ and antisense 
5′AAAATATCTCGAGCCCCCACCCCTGCCTTGT3′. The PCR product was digested with SalI and EcoRV and 
introduced into pCXGb plasmid as described earlier33.
Cells were transfected with miR-451 plasmid using X-remeGENE HPDNA transfection reagent (Roche 
Applied Science, Indianapolis, USA). Typically, 1 μg and 5 μg of miR-451 plasmid were used for 6-well dish and 
10-cm dish of cells at around 70% confluency, respectively. The transfection efficiency was determined by GFP 
fluorescence. Vector containing GFP encoding, without miR, sequence was used as an empty control.
Cell viability, proliferation and colony forming assays. For short-term cell viability, 5 × 103 control 
(untransfected), vector-transfected and miR-451 transfected cells were plated in 96-well plates, incubated at 37 °C 
for 48 h followed by addition of MTT (100 μl, 5 mg/ml in PBS) (Sigma-Aldrich, Missouri, USA) to each well and 
further incubation at 37 °C for 4 h. The supernatant was replaced with 100 μl of dimethyl sulfoxide (DMSO) and 
the chromophore was quantitated at 570 nm, using microplate reader (Infinite M200 PRO, TRCAN).
For cell proliferation assay, equal number of control (untransfected), vector-transfected and miR-451 trans-
fected cells were plated in 12-well plates. Cultured cells were harvested at indicated time points. The viable cells 
were counted by trypan blue exclusion assay using TC20TM Automated Cell Counter (Bio-Rad, Hercules, CA, 
USA). Growth curves were generated for each cell line from three independent experiments.
Gene (human) Sequence (5′-3′)
p21WAF1 forward GAGGCCGGGATGAGTTGGGAGGAG
p21WAF1 reverse CAGCCGGCGTTTGGAGTGGTAGAA
Cyclin D1 forward TCCTCTCCAAAATGCCAGAG
Cyclin D1 reverse GGCGGATTGGAAATGAACTT
CDK4 forward TCGAAAGCCTCTCTTCTGTG
CDK4 reverse TACATCTCGAGGCCAGTCAT
pRb forward GGAAGCAACCCTCCTAAACC
pRb reverse TTTCTGCTTTTGCATTCGTG
p53 forward TAACAGTTCCTGCATGGGCGGC
p53 reverse AGGACAGGCACAAACACGCACC
HDM2 forward TAGTATTTCCCTTTCCTTTGATGA
HDM2 reverse CACTCTCCCCTGCCTGATAC
CARF forward TCAAAGTGACAGATGCTCCA
CARF reverse CGTTGAACTGTTTTCCTGCT
18s forward CAGGGTTCGATTCCGTAGAG
18s reverse CCTCCAGTGGATCCTCGTTA
Table 1. qRT-PCR primer set sequences.
miR-451 UGGGUAUAGCAAGAGAACCAUUACCAUUACUAAACUCAG UAAUGGUAACGGUUUCCUUGCCAUUCCCA
RNU6B GCAAGGATGACACGCAAATTCGTGAAGCGTTCCATATTTTT
Table 2. Stem loop sequence.
www.nature.com/scientificreports/
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Effect of miR-451 on long-term proliferation of cells was determined by colony forming assay. Control 
(untransfected) or transfected cells (500/well) were plated in 6-well plates. The cells were cultured for next two 
weeks with regular (every third day) change of culture medium until colonies appeared. Colonies were fixed with 
methanol/acetone (1/1, v/v) for 10 min at 4 °C, stained with 0.1% Crystal violet for overnight, de-stained with 
water. Plates were dried and photographed using scanner (EPSON). Colonies were counted and statistical analysis 
was performed as described below.
Flow cytometry analysis. Equal number of control (untransfected) and transfected cells were seeded in 
10-cm dishes. After 24 h of seeding, cells were cultured in serum free medium for 24 h followed by harvest-
ing using 0.25% trypsinization. Cell pellets were washed with cold PBS and then added, drop by drop into the 
pre-cooled 70% ethanol to fix the cells. The fixed cells were stored at −20 °C for 24 h to until further use. The 
cells were centrifuged at 500 × g for 5 min, washed with cold PBS twice, re-suspended in 1 ml cold PBS and were 
treated with RNase A (100 μg/ml) at 37 °C for 1 h to avoid false DNA-PI staining. RNase A-treated cells were cen-
trifuged to discard the supernatant. The pellet was re-suspended in 200 μl of Cell Cycle Guava reagent (Millipore, 
Billerica, MA, USA), mixed gently and incubated for 30 min in dark. The stained cells were subjected to cell cycle 
analysis using Guava PCA flow cytometer (Millipore), and FlowJo Software (version 7.6, Flow Jo, LLC, USA).
Apoptosis assay. Control (untransfected) U2OS (2 × 105) and their miR-451 or miR-33533 derivatives 
were seeded in 6-well plates. Twelve hours later, the cells were transfected with either miR-335 or miR-451 using 
X-remeGENE HPDNA transfection reagent. Cells were cultured for 48–72 h cells and were then harvested 
by trypsin (0.25%) and cells centrifuging at 500 × g for 10 min at 4 °C. Cells were re-suspended in medium to 
make the cells number between 2 × 105 ml. 100 μl of cells were incubated with 100 μl of Guava Nexin Reagents 
(Millipore, Billerica, MA, USA) for 20 min in dark, and analyzed by Guava PCA flow cytometer (Millipore). The 
data were further analyzed by using FlowJo Software (version 7.6, Flow Jo, LLC, USA).
Luciferase reporter assay. pMIR-CARF-3′UTR plasmid was used as described earlier33. The pGL4-p53-
3′UTR and pGL4-p21-3′UTR were generously provided by Dr. Chae-Ok Yun (Hanyang University, Seoul, South 
Korea). Equal number of control (untransfected) and transfected cells were plated in 6-well plates. Cells were 
transfected with 1 μg of luciferase constructs (pGL4-p53-3′UTR, pGL4-p21-3′UTR or pMIR-CARF-3′UTR) 
and 100 ng of control vector oligonucleotide (pRL-TK or pMIR-REPORTTM β-gal control plasmid) using 
X-remeGENE HPDNA transfection reagent (Roche Applied Science, Indianapolis, USA). Cells were harvested at 
70% confluency followed by quantitation of luciferase activity using Dual-Luciferase Reporter Assay System and 
Tecan Infinite M200 Pro Microplate Reader (TECAN) following the manufacturer’s instructions.
Western blotting. Cells were lysed in RIPA buffer (Thermo Scientific, Waltham, MA, USA) supplemented with 
a protease inhibitor cocktail (Roche). The protein concentrations were determined by using the Pierce BCA Protein 
Assay Kit (Thermo Scientific). 20 μg of protein for each sample were resolved in SDS-polyacrylamide gel, and elec-
troblotted onto PVDF membranes (Millipore). Membranes were blocked in 3% BSA in TBS-T. The membranes were 
incubated with following primary antibodies: anti-p53 (DO-1), anti-MDM2 (HDM2-232), anti-cyclin D1 (72-13 G), 
anti-Cdk4 (C-22), anti-E2F-5 (MH5), anti-NFkB p65 (sc-109), anti-GFP (B-2) from Santa Cruz Biotechnology (Santa 
Cruz, CA, USA); anti-p21WAF1 (12D1), anti-Phospho-RB (Ser780), anti-Rb (4H1) from Cell signaling (Danvers, MA, 
USA) and anti-CARF (FL-10)44. Anti-β-actin antibody (AC-15) (Abcam, Cambridge, MA, USA) was used to deter-
mine the level of actin expression (as an internal loading control). All experiments were performed in triplicates. 
Quantitation of immunoblots was performed using the ImageJ software (National Institute of Health, Bethesda, MD).
Immunostaining. Control (untransfected) and transfected cells (5 × 104 cells/well) were seeded on 18-mm glass 
coverslips placed in 12-well culture dish. Cells were washed with cold PBS, fixed by using pre-cold methanol/acetone 
(1:1) mixture for 10 min at 4 °C and permeabilized using 0.5% Triton X-100 in PBS (PBS-T) for 10 min. The fixed cells 
were blocked with 0.2% BSA in PBS and were then incubated with specific primary antibodies as described above, for 
1 h at room temperature or overnight at 4 °C. After washing cells with PBS-T for three times, they were incubated with 
Alexa-594-conjugated goat anti-mouse or anti-rabbit (Molecular Probes, Invitrogen) secondary antibodies. Nuclear 
staining was performed with Hoechst 33342 (Sigma) for 10 min in dark after washings (thrice) with PBS-T. Following 
three further washings with PBS-T, the cells were examined under Carl Zeiss microscope (Axiovert 200 M, Tokyo, 
Japan). Images were quantified by ImageJ software (National Institute of Health, Bethesda, MD).
In vivo tumor formation assay. Four-weeks old female BALB/c nude mice were used for subcutaneous 
xenograft experiments. Mice (five per group) were subcutaneously injected with 5 × 106 human lung cancer A549 
cells (control, untransfected and miR-451 transfected cells) in 0.2 ml of PBS. Cells formed tumors in 10 days. Mice 
body weight; general activity (movements and eating behavior) and tumor volume were monitored every 2 days. 
Volume of the subcutaneous tumors was calculated as V = L × W2/2, where L was length and W was the width of 
the tumor, respectively. All animal experiments were performed following the protocols for animal experiments 
recognized and approved by the Animal Care and Use Committee, Institute of Laboratory Animal Science of 
Peking Union Medical College (ILAS-PG-2014-018).
Statistical analysis. All experiments were carried out, at least, three times, and data were expressed as 
mean ± standard deviation (SD). As shown in figures, the data were with respect to control (untransfected) or 
vector-transfected set either at 100 or 1. Two-tailed Student’s t-test or nonparametric ManneWhitney U-test, 
whichever was applicable, was used to determine the degree of significance between the control and experimental 
sample. Statistical significance was defined as significant (*p-value ≤ 0.05), very significant (**p-value ≤ 0.01) 
and very very significant (***p-value ≤ 0.01).
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